Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Budweiser

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
International Journal of Cancer|February 9, 2023
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN studyTobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Afatinib as first-line treatment in patients with <i>EGFR</i>-mutated non-small cell lung cancer in routine clinical practiceWolfgang M Brückl, Martin Reck, Frank Griesinger, et al.
Annals of the American Thoracic Society|February 6, 2020
The Effect of Hospital Discharge with Empiric Noninvasive Ventilation on Mortality in Hospitalized Patients with Obesity Hypoventilation Syndrome. An Individual Patient Data Meta-AnalysisBabak Mokhlesi, Juan Fernando Masa, Majid Afshar, et al.
ERJ Open Research|June 10, 2025
Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registryJürgen Behr, Michael Kreuter, Andreas U Guenther, et al.
Respiration; International Review of Thoracic Diseases|February 5, 2026
Sex-specific phenotypes and outcomes in non‑IPF interstitial lung disease: results from the INSIGHTS‑ILD registryDirk Koschel, Francesco Bonella, Andreas Günther, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
International Journal of Cancer|February 9, 2023
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN studyTobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Afatinib as first-line treatment in patients with <i>EGFR</i>-mutated non-small cell lung cancer in routine clinical practiceWolfgang M Brückl, Martin Reck, Frank Griesinger, et al.
Annals of the American Thoracic Society|February 6, 2020
The Effect of Hospital Discharge with Empiric Noninvasive Ventilation on Mortality in Hospitalized Patients with Obesity Hypoventilation Syndrome. An Individual Patient Data Meta-AnalysisBabak Mokhlesi, Juan Fernando Masa, Majid Afshar, et al.
ERJ Open Research|June 10, 2025
Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registryJürgen Behr, Michael Kreuter, Andreas U Guenther, et al.
Respiration; International Review of Thoracic Diseases|February 5, 2026
Sex-specific phenotypes and outcomes in non‑IPF interstitial lung disease: results from the INSIGHTS‑ILD registryDirk Koschel, Francesco Bonella, Andreas Günther, et al.
Pageof 7